Products

MedicaMetrix produces urological medical devices with demonstrated “comparative effectiveness” to reduce the cost of healthcare while improving clinical outcomes. Its first product, ProstaGlove™, is designed to improve the diagnosis and treatment of prostate cancer by enabling the use of PSA Density (PSAD) as a marker.

MedicaMetrix's first product is a medical device for Urology, and specifically for the diagnosis of prostate cancer. ProstaGlove™ provides a quantitative, office-based measurement of prostate volume at a fraction of the cost of trans-rectal ultra-sound (TRUS) and trans-rectal MRI.

Not available for Sale in the United States.
CAUTION – Investigational device. Limited by Federal law to investigational use only.